Low Blood Pressure Clinical Trials

Find Low Blood Pressure Clinical Trials Near You

Predictive Value of Baseline Perfusion Index for Spinal Anesthesia-Induced Hypotension in Healthy Patients Undergoing Knee Arthroscopy: A Prospective Observational Trial

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This prospective observational study aims to investigate the role of the baseline perfusion index (PI) in predicting spinal anesthesia-induced hypotension (SAIH) in ASA I-II patients undergoing day-case knee arthroscopy. Spinal anesthesia is a widely preferred technique for lower extremity surgeries, including knee arthroscopy. However, sympathetic blockade during spinal anesthesia frequently leads to significant hemodynamic instability, particularly hypotension, which can result in adverse perioperative outcomes. While age and baseline blood pressure are traditional risk factors, they often fail to accurately predict the onset of hypotension in healthy populations. The perfusion index (PI), a non-invasive parameter measured via pulse oximetry, reflects peripheral vascular tone and baseline sympathetic activity. An elevated baseline PI indicates baseline vasodilation and a higher susceptibility to sympathectomy, potentially offering an early and non-invasive prediction of SAIH before the hemodynamic collapse occurs. The primary outcome of the study is the incidence of spinal anesthesia-induced hypotension (defined as a mean arterial pressure \< 65 mmHg or a decrease in systolic blood pressure \> 25% from baseline). Secondary outcomes include the onset time of sensory block, and intraoperative ephedrine and fluid requirements.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Between the ages of 18-65

• Having an ASA Score of I-II

• Including data collection of parts that underwent knee arthroscopy

Locations
Other Locations
Turkey
Ankara Etlik City Hospital
RECRUITING
Ankara
Contact Information
Primary
İbrahim MD Topcu, MD
ibrahimtpc78@gmail.com
05437860316
Backup
Musa Ass. Prof Zengin, Ass. Prof
musazengin@gmail.com
05071302750
Time Frame
Start Date: 2026-08-06
Estimated Completion Date: 2026-12-28
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Ankara Etlik City Hospital

This content was sourced from clinicaltrials.gov